Home
/ SNBL
/ Financials & Metrics

SNBL (2395.T) stock price, revenue, and financials

SNBL market cap is ¥81.1 b, and annual revenue was ¥17.75 b in FY 2022

View Company

¥81.1 B

2395.T Mkt cap, 08-Jun-2022

¥17.7 B

SNBL Revenue FY, 2022

SNBL Gross profit (FY, 2022)10.7 B

SNBL Net income (FY, 2022)7.2 B

SNBL EBITDA (FY, 2022)7.1 B

SNBL EBIT (FY, 2022)5.7 B

SNBL Cash, 31-Mar-20226.6 B

SNBL EV83.6 B

SNBL Revenue Breakdown

Business Segment

Embed Graph

SNBL revenue breakdown by business segment: 5.5% from OTHER NONDISCLOSED, 96.1% from OTHER SCHOOLS and -1.5% from Other

Annual

JPY	FY, 2018	FY, 2019	FY, 2020	FY, 2021	FY, 2022
Revenue	16.6b	15.7b	14.6b	15.1b	17.7b
Cost of goods sold	(10.2b)	(8.3b)	(5.9b)	(6.5b)	(7.0b)
Gross profit	6.4b	7.3b	8.7b	8.6b	10.7b
R&D expense	(518.4m)	(339.8m)	(400.9m)	(392.2m)	(425.1m)
Operating expense total	(5.7b)	(5.1b)	(5.2b)	(4.9b)	(5.3b)
Depreciation and amortization	(1.7b)	(1.7b)	(1.3b)	(1.8b)	(1.4b)
EBITDA	1.5b	2.6b	4.3b	4.6b	7.1b
EBIT	(564.8m)	496.5m	3.0b	2.7b	5.7b
Interest expense	(374.0m)	(377.8m)	(235.0m)	(184.9m)	(126.6m)
Interest income	9.1m	18.5m	9.3m	3.0m	8.3m
Pre tax profit	(1.5b)	1.7b	3.1b	4.2b	8.2b
Income tax expense	(2.0b)	308.1m	(414.5m)	(497.8m)	(1.0b)
Net Income	(3.5b)	2.0b	2.6b	3.7b	7.2b

Quarterly

JPY	Q1, 2019	Q2, 2019	Q3, 2019	Q1, 2020	Q2, 2020	Q3, 2020	Q1, 2021	Q2, 2021	Q3, 2021	Q1, 2022	Q2, 2022	Q3, 2022
Revenue	3.7b	5.2b	3.4b	2.7b	3.7b	3.7b	3.2b	3.8b	3.4b	3.0b	4.9b	5.0b
Cost of goods sold	(2.1b)	(3.0b)	(1.5b)	(966.1m)	(1.4b)	(1.6b)	(1.3b)	(1.7b)	(1.5b)	(1.2b)	(1.9b)	(2.0b)
Gross profit	1.6b	2.1b	1.9b	1.8b	2.3b	2.0b	1.9b	2.1b	1.9b	1.8b	3.0b	3.0b
R&D expense	(78.3m)	(225.7m)	81.0m	(81.8m)	(92.2m)	(95.0m)	(84.0m)	(83.0m)	(118.0m)	(76.8m)	(103.2m)	(139.0m)
Operating expense total	(1.4b)	(1.7b)	(1.1b)	(1.2b)	(1.2b)	(1.2b)	(1.1b)	(1.1b)	(1.1b)	(1.1b)	(1.3b)	(1.4b)
Depreciation and amortization	(330.9m)	(458.8m)	(258.5m)	(280.4m)	(285.7m)	(318.7m)	(282.9m)	(293.9m)	(307.8m)	(285.1m)	(281.9m)	(299.2m)
EBITDA	221.7m	472.7m	867.2m	679.5m	1.2b	1.0b	1.1b	1.1b	896.0m	1.3b	2.0b	2.1b
EBIT	(133.5m)	(142.7m)	602.3m	390.0m	887.2m	710.2m	807.8m	758.7m	587.1m	999.1m	1.6b	1.8b
Interest expense	(92.0m)	(90.7m)	(86.2m)	(50.8m)	(73.1m)	(56.1m)	(51.7m)	(49.4m)	(43.1m)	(35.4m)	(33.5m)	(29.4m)
Interest income	4.1m	5.5m	3.4m	2.8m	3.2m	2.0m	1.1m	364.0k	334.0k	683.0k	1.3m	3.2m
Pre tax profit	536.3m	92.8m	776.9m	45.0m	1.2b	856.9m	731.4m	569.0m	385.7m	2.0b	1.9b	2.1b
Income tax expense	(141.5m)	436.2m	(141.7m)	(83.4m)	(216.6m)	(111.3m)	(86.5m)	(70.7m)	(42.3m)	(198.6m)	(203.9m)	(387.0m)
Net Income	394.8m	529.0m	635.2m	(38.4m)	991.2m	745.6m	644.9m	498.3m	343.4m	1.8b	1.7b	1.8b

Annual

JPY	FY, 2018	FY, 2019	FY, 2020	FY, 2021	FY, 2022
Cash	5.3b	5.1b	5.2b	7.2b	6.6b
Accounts Receivable	2.5b	1.9b	2.5b	3.0b	3.5b
Inventories	6.4b	3.6b	4.0b	4.1b	4.4b
Current Assets	15.3b	11.7b	12.4b	14.8b	16.1b
PP&E	14.7b	13.7b	13.7b	12.9b	13.2b
Total Assets	57.6b	54.3b	39.0b	37.0b	39.3b
Accounts Payable	84.6m	36.6m	119.3m	95.0m	64.6m
Short-term debt	11.5b	11.3b	6.0b	3.5b	2.9b
Current Liabilities	20.0b	17.8b	13.0b	11.9b	13.4b
Long-term debt	7.4b	4.6b	8.9b	9.2b	6.2b
Non-Current Liabilities	11.4b	8.1b	9.7b	9.2b	6.2b
Total Debt	18.9b	16.0b	14.9b	12.7b	9.1b
Total Liabilities	31.4b	25.9b	22.6b	21.1b	19.6b
Common Stock	9.7b	9.7b	9.7b	9.7b	9.7b
Additional Paid-in Capital	10.4b	10.4b	5.2b	2.3b	2.3b
Retained Earnings	(12.1b)	(10.1b)	(2.5b)	3.9b	10.2b
Total Equity	26.2b	28.5b	16.4b	15.8b	19.7b

Quarterly

JPY	Q1, 2019	Q2, 2019	Q3, 2019	Q1, 2020	Q2, 2020	Q3, 2020	Q1, 2021	Q2, 2021	Q3, 2021	Q1, 2022	Q2, 2022	Q3, 2022
Cash	4.8b	5.7b	4.7b	4.1b	4.6b	4.0b	6.2b	5.4b	6.4b	5.4b	5.3b	5.6b
Accounts Receivable	1.5b	1.8b	1.8b	1.6b	1.6b	2.1b	2.0b	2.4b	2.5b	2.0b	2.4b	3.1b
Inventories	6.5b	3.8b	3.7b	4.2b	4.2b	4.2b	4.2b	4.1b	4.2b	4.3b	4.3b	4.2b
Current Assets	13.7b	12.4b	11.2b	10.6b	11.4b	11.0b	13.4b	12.5b	13.7b	13.4b	14.0b	15.4b
PP&E	14.4b	14.0b	14.0b	13.6b	13.5b	13.7b	13.6b	13.4b	13.3b	12.4b	12.7b	13.0b
Total Assets	55.7b	62.4b	57.7b	47.4b	44.3b	39.3b	41.6b	35.4b	35.8b	37.3b	36.8b	37.4b
Accounts Payable	157.2m	125.8m	61.3m	173.1m	76.0m	201.9m	59.8m	93.3m	126.4m	64.2m	45.6m	78.0m
Short-term debt	11.5b	13.2b	11.6b	11.4b	5.8b	6.2b	4.5b	4.1b	3.8b	3.2b	3.0b	3.0b
Current Liabilities	19.5b	18.8b	17.1b	17.3b	12.1b	12.5b	10.4b	10.2b	10.8b	10.8b	11.0b	11.4b
Long-term debt	7.0b	5.7b	5.1b	4.1b	9.1b	8.7b	11.8b	10.5b	10.2b	8.7b	7.7b	7.2b
Non-Current Liabilities	10.8b	10.7b	9.1b	6.1b	11.0b	9.3b	13.0b	10.6b	10.2b	8.7b	7.7b	7.2b
Total Debt	18.5b	18.9b	16.7b	15.5b	14.9b	14.8b	16.3b	14.7b	14.0b	11.9b	10.6b	10.2b
Total Liabilities	30.2b	29.5b	26.2b	23.3b	23.1b	21.8b	23.4b	20.7b	21.0b	19.5b	18.7b	18.7b
Common Stock	9.7b	9.7b	9.7b	9.7b	9.7b	9.7b	9.7b	9.7b	9.7b	9.7b	9.7b	9.7b
Additional Paid-in Capital	10.4b	10.4b	10.4b	5.2b	5.2b	5.2b	2.3b	2.3b	2.3b	2.3b	2.3b	2.3b
Retained Earnings	(11.7b)	(11.1b)	(10.5b)	(5.1b)	(4.2b)	(3.4b)	836.0m	1.3b	1.7b	4.9b	6.6b	8.3b
Total Equity	25.4b	32.9b	31.5b	24.1b	21.1b	17.5b	18.2b	14.7b	14.8b	17.8b	18.1b	18.7b

Annual

JPY	FY, 2018	FY, 2019	FY, 2020	FY, 2021	FY, 2022
Net Income	(1.5b)	1.7b	3.1b	4.2b	8.2b
Depreciation and Amortization	1.5b	1.4b	1.2b	1.2b	1.2b
Accounts Receivable	285.8m	(149.2m)	(619.0m)	(343.5m)	(480.9m)
Inventories	398.3m	(424.5m)	(445.3m)	(71.7m)	(371.1m)
Accounts Payable	(2.3m)	119.2m	82.7m	(24.2m)	(36.7m)
Cash From Operating Activities	1.3b	2.9b	3.0b	4.7b	6.0b
Cash From Investing Activities	837.8m	434.8m	(1.5b)	(268.7m)	(4.3b)
Short-term Borrowings	1.1b	977.6m	(5.9b)	(2.0b)	(6.1m)
Long-term Borrowings	(5.3b)	(4.5b)	4.7b	(258.2m)	(4.1b)
Dividends Paid			(196.8m)	(209.2m)	(829.5m)
Cash From Financing Activities	(4.2b)	(3.5b)	(1.4b)	(2.5b)	(4.9b)
Net Change in Cash	(2.1b)	(159.3m)	108.5m	2.0b	(2.7b)

Quarterly

JPY	Q2, 2019	Q2, 2020	Q2, 2021	Q2, 2022
Net Income	629.1m	1.3b	1.3b	3.9b
Depreciation and Amortization	788.7m	563.6m	574.8m	560.9m
Accounts Receivable	454.8m	353.1m	147.7m	518.2m
Inventories	(547.8m)	(646.1m)	(37.2m)	(373.7m)
Accounts Payable	195.2m	39.5m	(25.9m)	(57.6m)
Cash From Operating Activities	1.2b	1.3b	1.0b	1.6b
Cash From Investing Activities	(416.4m)	(510.3m)	(332.8m)	380.7m
Short-term Borrowings	2.4b	(6.4b)	(2.0b)
Long-term Borrowings	(2.9b)	5.2b	1.7b	(2.1b)
Dividends Paid		(124.9m)	(205.8m)	(825.6m)
Cash From Financing Activities	(499.1m)	(1.3b)	(477.7m)	(2.9b)
Net Change in Cash	382.0m	(515.1m)	233.0m	(877.0m)

	Nov, 2020
Awards	2
Certifications	1
Patents (US)	26
Trademarks (US)	5
Types of Services	4

Culture & Values

2.6

Work/Life Balance

2.6

Senior Management

2.2

Salary & Benefits

2.7

Career Opportunities

2.3

Source

View SNBL profile

Competitors

Charles River Laboratories

Healthcare - Public

Labcorp Drug Development

Manufacturing & Industrial - Subsidiary

Compare competitors

SNBL (2395.T) stock price, revenue, and financials

¥81.1 B

¥17.7 B

SNBL Revenue Breakdown

SNBL Income Statement

Annual

Revenue

Cost of goods sold

Gross profit

R&D expense

Operating expense total

Depreciation and amortization

EBITDA

EBIT

Interest expense

Interest income

Pre tax profit

Income tax expense

Net Income

Quarterly

Revenue

Cost of goods sold

Gross profit

R&D expense

Operating expense total

Depreciation and amortization

EBITDA

EBIT

Interest expense

Interest income

Pre tax profit

Income tax expense

Net Income

SNBL Balance Sheet

Annual

Cash

Accounts Receivable

Inventories

Current Assets

PP&E

Total Assets

Accounts Payable

Short-term debt

Current Liabilities

Long-term debt

Non-Current Liabilities

Total Debt

Total Liabilities

Common Stock

Additional Paid-in Capital

Retained Earnings

Total Equity

Quarterly

Cash

Accounts Receivable

Inventories

Current Assets

PP&E

Total Assets

Accounts Payable

Short-term debt

Current Liabilities

Long-term debt

Non-Current Liabilities

Total Debt

Total Liabilities

Common Stock

Additional Paid-in Capital

Retained Earnings

Total Equity

SNBL Cash Flow

Annual

Net Income

Depreciation and Amortization

Accounts Receivable

Inventories

Accounts Payable

Cash From Operating Activities

Cash From Investing Activities

Short-term Borrowings